Navigation Links
Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
Date:7/24/2008

REHOVOT, Israel and JERSEY CITY, New Jersey, July 24 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it has successfully completed the acquisition of Parkway Clinical Laboratories Inc. ("Parkway"), a privately-held company owning a CLIA-certified lab located in Bensalem, Pennsylvania, for an aggregate purchase price of $2,900,000, consisting of $1,900,000 in cash and $1,000,000 of Rosetta's ordinary shares. An additional $300,000 will be payable upon the achievement of certain milestones. The lab owned by Parkway is an CLIA-certified clinical reference laboratory with an expected $2.7M in revenues and break-even operating income in 2008.

The acquisition is expected to allow Rosetta Genomics to expedite development and validation of its microRNA-based diagnostic tests both in the U.S. and worldwide. In addition, ownership of the CLIA-certified lab will allow Rosetta Genomics to control the commercialization of its diagnostics, including marketing, sales, and reimbursement strategy. As previously disclosed, the first three of Rosetta Genomics' microRNA-based tests expected to enter development and validation at Parkway's facilities this year:

- Differentiating squamous from non-squamous non-small cell

lung cancer- This test is designed to differentiate squamous from

non-squamous non-small cell lung cancer (NSCLC) using a single

microRNA. The ability of physicians to accurately differentiate

squamous from non-squamous NSCLC is an important treatment guide.

Certain angiogenesis inhibitors for non-squamous NSCLC include a

black-box warning about substantially highe
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
2. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
3. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
4. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
5. /C O R R E C T I O N -- Rosetta Genomics Ltd/
6. Rosetta Genomics Reports First Quarter 2008 Financial Results
7. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
8. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
9. Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference
10. Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics Scientists and Collaborators in Nature Biotechnology
11. Rosetta Genomics Announces Allowance of Two Additional microRNA Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of strategic ... business, and media events in the United States ... associate Virginia Cox , JD, is returning to the firm,s ... Cox re-joins 3D after more than two years of service ...
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational research ... Alliqua is an emerging biomedical company acquiring, developing, manufacturing, ... market. , Free report download: http://equitiesiq.com/reports/alliqua/ , ... management team and Board, which launched the company’s new ...
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
(Date:1/14/2014)... In recent years, growing suspicion about ... product development and promotion has led to unprecedented levels ... by concerns about the insidious impact of commercialization of ... fines to the world’s biggest pharmas for illegal marketing ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... A key lawmaker who often disagrees with Governor Jim ... saw nothing inappropriate about the governor's use of an executive ... cell companies. , ,Meanwhile, the executive order, signed Tuesday at ... the director of Pro Life Wisconsin. , ,Ted Kanavas, R-Brookfield, ...
... GE Healthcare has received federal approval for yet ... for the estimated 20% of Americans that are considered obese. ... the Food and Drug Administration for its new wide bore ... The system is designed to meet growing demand for better ...
... Is your brand valuation worth a billion dollars today? Maybe yes ... At the end of the day, all the work you have ... and services in your marketplace adds up in an abstract space ... equity can be measured as a real, soft asset. It can ...
Cached Biology Technology:Republican sees nothing wrong with Doyle's use of executive order 2FDA okays new GE tomography system 2Is your brand worth billions? 2Is your brand worth billions? 3
(Date:7/9/2014)... from China challenges the commonly held belief that birds ... to fly. The birdlike fossil is actually not a ... of a tiny tree-climbing animal that could glide, say ... Blanding, Utah, and Alan Feduccia of the University of ... of Ornithology . , The fossil of the ...
(Date:7/9/2014)... measurement results accrue. To completely and systematically archive ... In fact, researchers in the life sciences spend ... to an online survey of 70 people working ... for Applied Information Technology FIT in Sankt Augustin. ... no centralized or structured approach to data collection ...
(Date:7/9/2014)... with high levels of vitamin D in their blood are ... , Patients with the highest levels of vitamin D have ... lowest levels, the findings reveal. , The study is the ... bowel cancer patients after their diagnosis which includes that ... sources with their long term survival prospects. , ...
Breaking Biology News(10 mins):Researchers declassify dinosaurs as being the great-great-grandparents of birds 2Managing the data jungle 2Managing the data jungle 3
... to stop the spread of drug resistance in typhoid fever, ... published in the journal eLife . The ... bacteria can out-compete drug sensitive strains when grown in the ... is transmitted by consuming food or drink that is contaminated ...
... 9, 2013 /PRNewswire-iReach/ -- With the holiday season comes the ... American will put on up to five pounds in just ... CDC (Center for Disease Control) more than 65% of Americans ... obese. (Photo: http://photos.prnewswire.com/prnh/20131209/MN29878 ) ...
... inhibitors (SSRIs) are the most commonly prescribed antidepressants, but ... often try several different SSRI medications, each with a ... is effective. It takes three to four weeks to ... and their families continue to suffer. Now researchers ...
Cached Biology News:Antibiotic-resistant typhoid likely to spread despite drug control program 2HCG Injections and B12 shots now in stock at US Vitamin Injections Site 2A personal antidepressant for every genome 2A personal antidepressant for every genome 3
MAb to Desmoplakin I & II Desmoplakin I & II...
... in conjuction with Annexin V-FITC to distinguish ... of apoptosis (Annexin V positive, PI negative) ... of apoptosis or already dead (Annexin V-FITC ... the orange range of the spectrum using ...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
... Sf9 Insect Cells are derived from the Spodoptera ... optimal growth, use in transfections, plaque assays, virus ... in a protocol that optimizes recovery of viable ... in serum-free BacVector Insect Cell Medium and can ...
Biology Products: